Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, Domenicali M, De Notariis S, Roda E, Bernardi M.

J Hepatol. 2001 Apr;34(4):570-5.

PMID:
11394657
2.

Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.

Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G.

Anticancer Res. 2003 Mar-Apr;23(2C):1747-53.

PMID:
12820452
3.

The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.

Peng YC, Chan CS, Chen GH.

Hepatogastroenterology. 1999 Nov-Dec;46(30):3208-11.

PMID:
10626187
4.

Assessment of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma in Middle Eastern patients.

Sanai FM, Sobki S, Bzeizi KI, Shaikh SA, Alswat K, Al-Hamoudi W, Almadi M, Al Saif F, Abdo AA.

Dig Dis Sci. 2010 Dec;55(12):3568-75. doi: 10.1007/s10620-010-1201-x. Epub 2010 Apr 16.

PMID:
20397051
5.
6.

The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.

Huo TI, Hsia CY, Chu CJ, Huang YH, Lui WY, Wu JC, Lee PC, Chi CW, Lee SD.

J Surg Oncol. 2007 Jun 15;95(8):645-51.

PMID:
17530668
7.

Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.

Murugavel KG, Mathews S, Jayanthi V, Shankar EM, Hari R, Surendran R, Vengatesan A, Raghuram K, Rajasambandam P, Murali A, Srinivas U, Palaniswamy KR, Pugazhendhi T, Thyagarajan SP.

Int J Infect Dis. 2008 Nov;12(6):e71-6. doi: 10.1016/j.ijid.2008.04.010. Epub 2008 Jul 26.

8.

Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.

Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G.

Hepatogastroenterology. 2000 Nov-Dec;47(36):1654-8.

PMID:
11149026
9.

Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.

Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R.

Am J Gastroenterol. 2000 Apr;95(4):1036-40.

PMID:
10763956
10.

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.

Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.

J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.

PMID:
18422961
11.

Minor role of hepatitis B virus in the causation of chronic liver disease in Somalia indicated by a case-control study.

Bile KM, Abdirahman M, Aden C, Norder H, Magnius L, Lindberg G, Nilsson LH.

Trans R Soc Trop Med Hyg. 1991 Jan-Feb;85(1):104-8.

PMID:
1712517
12.
13.

Case-control study of hepatitis B virus infection in chronic liver disease and hepatocellular carcinoma.

de Franchis R, Primignani M, Vecchi M, Antoniozzi F, Colombo M, Colucci G, Tommasini M.

Ric Clin Lab. 1984 Jan-Mar;14(1):81-8.

PMID:
6328629
14.

Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.

Nguyen MH, Garcia RT, Simpson PW, Wright TL, Keeffe EB.

Hepatology. 2002 Aug;36(2):410-7.

PMID:
12143050
15.

Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.

Yano Y, Yamashita F, Sumie S, Ando E, Fukumori K, Kiyama M, Oyama T, Kuroki S, Kato O, Yamamoto H, Tanaka M, Sata M.

Am J Gastroenterol. 2002 Jan;97(1):156-61.

PMID:
11808941
16.

Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.

Radhika NS, Duseja A, Rajwanshi A, Gupta SK, Sehgal S, Suri S, Chawla Y.

Trop Gastroenterol. 2004 Jul-Sep;25(3):116-20.

PMID:
15682657
17.

Diagnosis of hepatocellular carcinoma by concanavalin A affinity electrophoresis of serum alpha-fetoprotein.

Saitoh S, Ikeda K, Koida I, Suzuki Y, Kobayashi M, Tsubota A, Arase Y, Chayama K, Murashima N, Kumada H.

Cancer. 1995 Oct 1;76(7):1139-44.

18.

Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.

Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD.

Am J Gastroenterol. 2000 Jun;95(6):1535-8.

PMID:
10894592
19.
20.

Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.

Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.

Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1417-24.

PMID:
19950803

Supplemental Content

Support Center